NEU 2.50% $15.59 neuren pharmaceuticals limited

Neuren Media and Analyst Coverage, page-996

  1. 377 Posts.
    lightbulb Created with Sketch. 19
    Well written G Chook. Agree the risks are getting less and still more positive news to be released. One major hurdle is Phase3 testing! Anyone have a time when that might be happening?
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.